Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno Medical PCLBKK:TM-R 76 Capex-to-Operating-Income is 0.19 as of Mar. 2026, which is 57% below its 10-year median of 0.44. GuruFocus rates BKK:TM-R with a GF Score™ of 76/100 and a GF Value™ of ฿2.99. The stock has 6 warning signs investors should review. Among 75 Medical Distribution companies, Techno Medical PCL ranks better than 68% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Techno Medical PCL (BKK:TM-R) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Techno Medical PCL Capex-to-Operating-Income Related Terms
Techno Medical PCL Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for Techno Medical PCL's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medical PCL Capex-to-Operating-Income Chart
BKK:TM-R vs MCK, COR, CAH: Capex-to-Operating-Income Comparison
For the Medical Distribution subindustry, Techno Medical PCL's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL Capex-to-Operating-Income vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 0.19 mean?
Techno Medical PCL (BKK:TM-R) has a Capex-to-Operating-Income of 0.19 as of Mar. 2026. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Techno Medical PCL and its competitors. This is 57% below median its historical median of 0.44. Over the past decade, Techno Medical PCL's Capex-to-Operating-Income has ranged from 0.12 to 8.65. According to the industry distribution chart, Techno Medical PCL ranks #24 out of 75 companies in the Medical Distribution industry, placing it in the top 32%.
Is Techno Medical PCL's Capex-to-Operating-Income too high?
Techno Medical PCL's current Capex-to-Operating-Income of 0.19 is 57% below median its 10-year median of 0.44. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 8.65. The Medical Distribution industry median Capex-to-Operating-Income is 0.27. Techno Medical PCL's value of 0.19 is 29.6% below this industry median. Based on the distribution chart, Techno Medical PCL ranks #24 out of 75 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Techno Medical PCL has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's Capex-to-Operating-Income compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Techno Medical PCL ranks #24 out of 75 companies for Capex-to-Operating-Income. This puts Techno Medical PCL in the upper half of its industry. The industry median Capex-to-Operating-Income is 0.27. Techno Medical PCL's value of 0.19 is 29.6% below this benchmark. Historically, Techno Medical PCL's own Capex-to-Operating-Income has ranged from 0.12 to 8.65 over the past decade. While the company's 10-year median is 0.44 vs. the industry median of 0.27, Techno Medical PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Medical Distribution company?
The median Capex-to-Operating-Income among Medical Distribution companies is 0.27, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current Capex-to-Operating-Income of 0.19 is 29.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Techno Medical PCL and its competitors. For the Medical Distribution industry, the median Capex-to-Operating-Income is 0.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current Capex-to-Operating-Income is 0.19, which is 57% below median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Techno Medical PCL (BKK:TM-R) has a current Capex-to-Operating-Income of 0.19. The stock's GF Value™ is ฿2.99, compared to a current price of ฿2.32 — trading 22.4% below its estimated fair value. The current Capex-to-Operating-Income is 0.19, which is 57% below median its 10-year median of 0.44 and 29.6% below the Medical Distribution industry median of 0.27. Techno Medical PCL's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM-R), the current Capex-to-Operating-Income is 0.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿2.32 is trading 22.4% below its estimated GF Value™ of ฿2.99.
Key valuation signals for BKK:TM-R:
Capex-to-Operating-Income: 0.19 (57% below median its 10-year median of 0.44)
GF Value™: ฿2.99 vs. price of ฿2.32 (22.4% below fair value)
Industry Position: 29.6% below the Medical Distribution median (#24 of 75)
No single metric tells the full story. See the BKK:TM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
76GF Score
Get the complete analysis for BKK:TM-R
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM-R has been successfully added to your 
